Pinehurst, NORTH%20CAROLINA4 Active Studies

Lung Cancer Clinical Trials in Pinehurst, NORTH%20CAROLINA

Find 4 actively recruiting lung cancer clinical trials in Pinehurst, NORTH%20CAROLINA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
1,219
Enrolling

Recruiting Lung Cancer Studies in Pinehurst

RecruitingPinehurst, NORTH%20CAROLINANCT05920356

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

The primary objectives are to compare progression-free survival (PFS) and overall survival (OS) in participants who receive sotorasib with platinum doublet chemotherapy versus participants who receive...

750 participants
Amgen
View Study Details
RecruitingPinehurst, NORTH%20CAROLINANCT06745323

A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC

The primary objective of this study is to describe the antitumor activity of tarlatamab in participants with small cell lung cancer (SCLC)....

240 participants
Amgen
View Study Details
RecruitingPinehurst, NORTH%20CAROLINANCT06667908

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study is to determine whether JNJ-90301900 added to concurrent platinum-based doublet chemotherapy with radiation therapy (cCRT) followed by consolidation immunotherapy (cIT) can i...

130 participants
Johnson & Johnson Enterprise Innovation Inc.
View Study Details
RecruitingPinehurst, NORTH%20CAROLINANCT05168566

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

This is a Phase 2b, multicenter, open-label study to evaluate the safety and efficacy of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC (Non-resistant Uncommon EGFR Mutations Only, ...

99 participants
Teligene US
View Study Details

About Lung Cancer Clinical Trials in Pinehurst

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 4 lung cancer clinical trials recruiting participants in Pinehurst, NORTH%20CAROLINA. These studies are seeking a combined 1,219 participants. Research is being sponsored by Amgen, Johnson & Johnson Enterprise Innovation Inc., Teligene US. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Pinehurst — FAQ

Are there lung cancer clinical trials in Pinehurst?

Yes, there are 4 lung cancer clinical trials currently recruiting in Pinehurst, NORTH%20CAROLINA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pinehurst?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pinehurst research site will contact you about next steps.

Are clinical trials in Pinehurst free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pinehurst studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 4 active trials in Pinehurst are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated March 2, 2026 from ClinicalTrials.gov